BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3397638)

  • 1. Serum immunoglobulin E levels in patients with head and neck cancer.
    Lal H; Singh B; Wig U; Saini AS
    J Laryngol Otol; 1988 May; 102(5):432-4. PubMed ID: 3397638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum phosphohexose isomerase levels in patients with head and neck cancer.
    Goel H; Kohli GS; Lal H
    J Laryngol Otol; 1986 May; 100(5):581-5. PubMed ID: 3701205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunobiologic staging of patients with carcinoma of the head and neck.
    Katz AE
    Laryngoscope; 1983 Apr; 93(4):445-63. PubMed ID: 6339850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum enzymes in head and neck cancer III.
    Lal H; Munjal SK; Wig U; Saini AS
    J Laryngol Otol; 1987 Oct; 101(10):1062-5. PubMed ID: 3681130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergy symptoms, serum total immunoglobulin E, and risk of head and neck cancer.
    Liao HC; Wu SY; Ou CY; Hsiao JR; Huang JS; Tsai ST; Huang CC; Wong TY; Lee WT; Chen KC; Fang SY; Wu JL; Huang TT; Wu YH; Hsueh WT; Yen CJ; Yang MW; Lin FC; Lai YH; Chang JY; Lin CL; Wang YH; Weng YL; Yang HC; Chen YS; Chang JS
    Cancer Causes Control; 2016 Sep; 27(9):1105-15. PubMed ID: 27443169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum immunoglobulin levels in patients with head and neck cancer (IgE, IgA, IgM, IgG).
    Vinzenz K; Pavelka R; Schönthal E; Zekert F
    Oncology; 1986; 43(5):316-22. PubMed ID: 3763126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: IgE serum-levels in cancer patients.
    Lancet; 1975 Feb; 1(7903):396-7. PubMed ID: 46543
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum enzymes in head and neck cancer. IV: 5-nucleotidase.
    Lal H; Kumar L; Kohli GS; Sharma A; Goel H
    J Laryngol Otol; 1989 Feb; 103(2):200-2. PubMed ID: 2538528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Illness stage and IgA-anti-Fab/F(ab')2 autoantibody activity in serum of patients with malignant head-neck tumors].
    Lorenz KJ; Süsal C; Opelz G; Maier H
    Laryngorhinootologie; 1996 Dec; 75(12):764-8. PubMed ID: 9081283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum magnesium levels in patients with head and neck cancer.
    Kohli GS; Bhargava A; Goel H; Yadav SP; Saini AS; Singh GP; Lal H
    Magnesium; 1989; 8(2):77-86. PubMed ID: 2755215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of immunosuppressive acidic protein and other immunological parameters in head and neck cancer patients.
    Nakashima T; Tanaka M; Okamura S
    J Laryngol Otol; 1991 Nov; 105(11):939-45. PubMed ID: 1761949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin A, G and E levels in Egyptians with cancer: influence of schistosomiasis.
    Pidcock NB; Cooper EH; el-Aaser AA; el-Sebai I
    Int J Cancer; 1984 Jun; 33(6):771-5. PubMed ID: 6735523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer.
    Süsal C; Maier H; Lorenz K; Opelz G
    Int J Cancer; 1994 Apr; 57(1):47-50. PubMed ID: 8150540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
    Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgE-mediated sensitization to malassezia in atopic dermatitis: more common in male patients and in head and neck type.
    Brodská P; Panzner P; Pizinger K; Schmid-Grendelmeier P
    Dermatitis; 2014; 25(3):120-6. PubMed ID: 24819285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the differences in levels of immunoglobulin G, A,and M in the course of malignant head and neck tumors].
    Adamiak G; Jurkiewicz D; Polberg K; Hermanowski M; Raczka A
    Otolaryngol Pol; 1995; 49 Suppl 20():133-7. PubMed ID: 9454119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral complications of experimental plasma exchange in head and neck cancer.
    Jackson MJ; Seder RH; Katz AE
    J Prosthet Dent; 1986 Jun; 55(6):718-22. PubMed ID: 3522867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.